GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InfuSystems Holdings Inc (AMEX:INFU) » Definitions » Piotroski F-Score
中文

InfuSystems Holdings (InfuSystems Holdings) Piotroski F-Score : 8 (As of Apr. 25, 2024)


View and export this data going back to 1992. Start your Free Trial

What is InfuSystems Holdings Piotroski F-Score?

Good Sign:

Piotroski F-Score is 8, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

InfuSystems Holdings has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for InfuSystems Holdings's Piotroski F-Score or its related term are showing as below:

INFU' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 8
Current: 8

During the past 13 years, the highest Piotroski F-Score of InfuSystems Holdings was 8. The lowest was 4. And the median was 6.


InfuSystems Holdings Piotroski F-Score Historical Data

The historical data trend for InfuSystems Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InfuSystems Holdings Piotroski F-Score Chart

InfuSystems Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 7.00 5.00 6.00 8.00

InfuSystems Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 4.00 6.00 7.00 8.00

Competitive Comparison of InfuSystems Holdings's Piotroski F-Score

For the Medical Instruments & Supplies subindustry, InfuSystems Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InfuSystems Holdings's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where InfuSystems Holdings's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -0.324 + 0.435 + 0.689 + 0.072 = $0.9 Mil.
Cash Flow from Operations was -0.151 + 2.452 + 4.264 + 4.658 = $11.2 Mil.
Revenue was 30.37 + 31.735 + 31.909 + 31.771 = $125.8 Mil.
Gross Profit was 15.54 + 16.442 + 16.246 + 14.881 = $63.1 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(99.388 + 102.261 + 102.749 + 102.071 + 102.915) / 5 = $101.8768 Mil.
Total Assets at the begining of this year (Dec22) was $99.4 Mil.
Long-Term Debt & Capital Lease Obligation was $34.9 Mil.
Total Current Assets was $30.6 Mil.
Total Current Liabilities was $15.7 Mil.
Net Income was -0.368 + -0.164 + 0.443 + 0.107 = $0.0 Mil.

Revenue was 26.763 + 27.042 + 27.279 + 28.83 = $109.9 Mil.
Gross Profit was 15.367 + 14.901 + 16.219 + 14.073 = $60.6 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(97.586 + 98.237 + 98.817 + 98.981 + 99.388) / 5 = $98.6018 Mil.
Total Assets at the begining of last year (Dec21) was $97.6 Mil.
Long-Term Debt & Capital Lease Obligation was $36.9 Mil.
Total Current Assets was $24.8 Mil.
Total Current Liabilities was $14.5 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

InfuSystems Holdings's current Net Income (TTM) was 0.9. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

InfuSystems Holdings's current Cash Flow from Operations (TTM) was 11.2. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=0.872/99.388
=0.0087737

ROA (Last Year)=Net Income/Total Assets (Dec21)
=0.018/97.586
=0.00018445

InfuSystems Holdings's return on assets of this year was 0.0087737. InfuSystems Holdings's return on assets of last year was 0.00018445. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

InfuSystems Holdings's current Net Income (TTM) was 0.9. InfuSystems Holdings's current Cash Flow from Operations (TTM) was 11.2. ==> 11.2 > 0.9 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=34.9/101.8768
=0.34257063

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=36.918/98.6018
=0.37441507

InfuSystems Holdings's gearing of this year was 0.34257063. InfuSystems Holdings's gearing of last year was 0.37441507. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=30.62/15.713
=1.94870489

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=24.779/14.467
=1.71279464

InfuSystems Holdings's current ratio of this year was 1.94870489. InfuSystems Holdings's current ratio of last year was 1.71279464. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

InfuSystems Holdings's number of shares in issue this year was 21.737. InfuSystems Holdings's number of shares in issue last year was 24.312. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=63.109/125.785
=0.50172119

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=60.56/109.914
=0.55097622

InfuSystems Holdings's gross margin of this year was 0.50172119. InfuSystems Holdings's gross margin of last year was 0.55097622. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=125.785/99.388
=1.26559544

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=109.914/97.586
=1.1263296

InfuSystems Holdings's asset turnover of this year was 1.26559544. InfuSystems Holdings's asset turnover of last year was 1.1263296. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+1+1+0+1
=8

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

InfuSystems Holdings has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

InfuSystems Holdings  (AMEX:INFU) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


InfuSystems Holdings Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of InfuSystems Holdings's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


InfuSystems Holdings (InfuSystems Holdings) Business Description

Traded in Other Exchanges
Address
3851 West Hamlin Road, Rochester Hills, MI, USA, 48309
InfuSystems Holdings Inc is a United States based healthcare service provider. It offers Infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from the locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The segments of the company are Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) services, of which key revenue is derived from the ITS segment.
Executives
Jerod Funke officer: EVP-Chief HR Officer 3851 WEST HAMLIN RD, ROCHESTER HILLS MI 48309
R. Rimmy Malhotra director C/O COMMAND CENTER, INC., 3609 S WADSWORTH BLVD., SUITE 250, LAKEWOOD CO 80235
Gregg Owen Lehman director 309 HADDON COURT, FRANKLIN X1 37067
Richard Dilorio officer: Executive Vice President 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Barry G Steele officer: Executive VP and CFO 500 TOWN CENTER DR., SUITE 200, DEARBORN MI 48126
Carrie Lachance officer: Executive VP and COO 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Christopher R. Sansone director C/O SANSONE ADVISORS, LLC, 151 BODMAN PLACE, SUITE 100, RED BANK NJ 07701
Addam Chupa officer: Executive VP and CIO 3851 WEST HAMLIN ROAD, ROCHESTER HILLS MI 48309
Kevin Whitman officer: VP and Corporate Controller 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Thomas Mark Ruiz officer: VP of Sales and Marketing 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Boyd Ralph F Jr director
Paul Andrew Gendron director 740 BANDIT TRAIL, KELLER TX 76248
Jeannine Sheehan officer: Chief Administrative Officer 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Blueline Capital Partners Ii, L.p. director 3480 BUSKIRK AVENUE, SUITE 214, PLEASANT HILL CA 94523
Meridian Tsv Ii, Lp 10 percent owner 405 WEED STREET, NEW CANAAN CT 06840